CMC

61.41

+1.84%↑

FUL

61.28

+3.39%↑

USAU

15.19

+8.27%↑

CMC

61.41

+1.84%↑

FUL

61.28

+3.39%↑

USAU

15.19

+8.27%↑

CMC

61.41

+1.84%↑

FUL

61.28

+3.39%↑

USAU

15.19

+8.27%↑

CMC

61.41

+1.84%↑

FUL

61.28

+3.39%↑

USAU

15.19

+8.27%↑

CMC

61.41

+1.84%↑

FUL

61.28

+3.39%↑

USAU

15.19

+8.27%↑

Search

Israel Chemicals Ltd

Закрыт

СекторСырье

5.18 -0.19

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

5.08

Макс.

5.25

Ключевые показатели

By Trading Economics

Доход

-202M

-73M

Продажи

-152M

1.7B

P/E

Средняя по отрасли

28.167

32.671

Прибыль на акцию

0.09

Дивидендная доходность

3.54

Рентабельность продаж

-4.292

Сотрудники

12,165

EBITDA

-145M

198M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+13.1% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

3.54%

3.04%

Следующий отчет о доходах

18 мая 2026 г.

Дата следующей выплаты дивидендов

17 июн. 2026 г.

Следующая эксдивидендная дата

3 июн. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-852M

6.5B

Предыдущая цена открытия

5.37

Предыдущая цена закрытия

5.18

Новостные настроения

By Acuity

50%

50%

74 / 150 Рейтинг в Basic materials

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Israel Chemicals Ltd График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

31 мар. 2026 г., 23:31 UTC

Популярные акции

Stocks to Watch: Nike, RH, NCino

31 мар. 2026 г., 22:35 UTC

Отчет

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 апр. 2026 г., 00:00 UTC

Приобретения, слияния, поглощения

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 мар. 2026 г., 23:50 UTC

Приобретения, слияния, поглощения

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 мар. 2026 г., 23:43 UTC

Обсуждения рынка

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 мар. 2026 г., 23:33 UTC

Обсуждения рынка
Главные новостные события

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 мар. 2026 г., 23:21 UTC

Отчет

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 мар. 2026 г., 23:14 UTC

Обсуждения рынка
Отчет

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 мар. 2026 г., 23:12 UTC

Обсуждения рынка

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke 2025 Loss Widens >000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 мар. 2026 г., 22:36 UTC

Отчет

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 мар. 2026 г., 21:46 UTC

Приобретения, слияния, поглощения

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 мар. 2026 г., 21:36 UTC

Обсуждения рынка

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 мар. 2026 г., 21:35 UTC

Отчет

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 мар. 2026 г., 21:35 UTC

Отчет

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 мар. 2026 г., 21:35 UTC

Отчет

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 мар. 2026 г., 21:33 UTC

Приобретения, слияния, поглощения

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 мар. 2026 г., 21:33 UTC

Отчет

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 мар. 2026 г., 21:32 UTC

Отчет

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 мар. 2026 г., 21:28 UTC

Отчет

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 мар. 2026 г., 21:26 UTC

Отчет

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 мар. 2026 г., 21:25 UTC

Отчет

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 мар. 2026 г., 21:24 UTC

Обсуждения рынка
Отчет

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 мар. 2026 г., 21:22 UTC

Отчет

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 мар. 2026 г., 21:22 UTC

Отчет

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 мар. 2026 г., 21:21 UTC

Отчет

Nike's Digital Channel Still Too Promotional, CFO Says

31 мар. 2026 г., 21:20 UTC

Отчет

Nike CEO: Converse Remains Important to Portfolio

Сравнение c конкурентами

Изменение цены

Israel Chemicals Ltd Прогноз

Целевая цена

By TipRanks

13.1% рост

Прогноз на 12 месяцев

Средняя 5.87 USD  13.1%

Максимум 6 USD

Минимум 5.6 USD

Основано на мнении 3 аналитиков Wall Street, спрогнозировавших целевые цены для Israel Chemicals Ltd на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

3 ratings

0

Покупка

3

Удержание

0

Продажа

Техническая оценка

By Trading Central

6.835 / 6.85Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Strong Bullish Evidence

Долгосрочная

Neutral Evidence

Настроения

By Acuity

74 / 150Рейтинг в Сырье

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Israel Chemicals Ltd

ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products. The Potash segment extracts potash from the Dead Sea; mines and produces potash and salt; produces polysulphate; produces, markets, and sells magnesium and magnesium alloys, as well as related by-products, including chlorine and sylvinite; and sells salt. This segment uses phosphate commodity products to produce specialty products; produces and markets phosphate-based fertilizers, as well as sulphuric acid, green phosphoric acid, and phosphate fertilizers; and offers Phosphate salts and acids for various industrial end markets, such as oral care, cleaning products, paints and coatings, water treatment, asphalt modification, construction, and metal treatment. It also develops and produces functional food ingredients and phosphate additives for use in the processed meat, poultry, seafood, dairy, beverage, and baked goods markets; and produces milk and whey proteins for the food ingredients industry. The Growing Solutions segment develops, manufactures, markets, and sells fertilizers based primarily on nitrogen, potash, and phosphate, including water soluble specialty, liquid, soluble, and controlled-release fertilizers. It sells its products through marketing companies, agents, and distributors. The company was formerly known as Israel Chemicals Ltd. and changed its name to ICL Group Ltd in May 2020. The company was incorporated in 1968 and is headquartered in Tel Aviv, Israel.
help-icon Live chat